We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Government response to the House of Commons Health Committee
First published during the 2010 to 2015 Conservative and Liberal Democrat coalition government
Standards and guidance for health professionals, managers and commissioners working in the NHS breast screening programme.
For manufacturers reporting adverse incidents with joint replacement implants under the vigilance system.
A retrospective, internal review of the actions of the MHRA and the Department of Health regarding Poly Implant Prothèse (PIP) breast implants, led by the Parliamentary Under-secretary of State for Quality Earl Howe.
UK update on Breast Implant Associated - Anaplastic Large Cell Lymphoma (BIA - ALCL)
This provides details for screening providers on moving from printed leaflets to digital alternatives.
Population screening programmes: NHS breast screening (BSP) programme. The pages tagged as BSP will appear here.
(All) uncertain evidence that women with breast implants may have a very small but increased risk of anaplastic large cell lymphoma (ALCL) of the breast - none reported in the UK. (MDA/2011/017)
Anastrozole is now authorised as a preventative treatment for post-menopausal women at moderate or high risk of breast cancer.
Following MHRA approval of a clinical trial, early breast cancer patients on endocrine-based therapy can benefit from a study with camizestrant.
NHS Breast Screening Programme position statement on reporting of breast density
This document provides advice to local breast screening services for assessing and interviewing overseas candidates for mammography posts.
This publication provides guidance on routine quality control tests for tomosynthesis systems carried out by medical physics services.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).